These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Recombinant growth hormone therapy for cystic fibrosis in children and young adults. Thaker V; Haagensen AL; Carter B; Fedorowicz Z; Houston BW Cochrane Database Syst Rev; 2015 May; (5):CD008901. PubMed ID: 25991406 [TBL] [Abstract][Full Text] [Related]
12. Dornase alfa for cystic fibrosis. Yang C; Chilvers M; Montgomery M; Nolan SJ Cochrane Database Syst Rev; 2016 Apr; 4():CD001127. PubMed ID: 27043279 [TBL] [Abstract][Full Text] [Related]
13. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Langton Hewer SC; Smyth AR Cochrane Database Syst Rev; 2014 Nov; (11):CD004197. PubMed ID: 25383937 [TBL] [Abstract][Full Text] [Related]
14. Drug therapies for reducing gastric acidity in people with cystic fibrosis. Ng SM; Moore HS Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD003424. PubMed ID: 27546383 [TBL] [Abstract][Full Text] [Related]
15. Oral steroids for long-term use in cystic fibrosis. Cheng K; Ashby D; Smyth RL Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD000407. PubMed ID: 26649765 [TBL] [Abstract][Full Text] [Related]
16. Drug treatments for managing cystic fibrosis-related diabetes. Onady GM; Stolfi A Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159 [TBL] [Abstract][Full Text] [Related]
18. Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis. Aslam AA; Higgins C; Sinha IP; Southern KW Cochrane Database Syst Rev; 2017 Jan; 1(1):CD012040. PubMed ID: 28102546 [TBL] [Abstract][Full Text] [Related]
19. Drug therapies for reducing gastric acidity in people with cystic fibrosis. Ng SM; Moore HS Cochrane Database Syst Rev; 2021 Apr; 4(4):CD003424. PubMed ID: 33905540 [TBL] [Abstract][Full Text] [Related]